BridgeMD
Tests treatment safety and results for Myocardial Ischemia
Official title Effectiveness of Inspiratory Muscle Training for People With Ischemic Heart Disease Revascularized by Percutaneous Transluminal Coronary Angioplasty.
ClinicalTrials.gov ID: NCT06681740
What this study is testing
- What it's testing
- Myocardial Ischemia (MI) consists of the narrowing of the internal lumen of the arteries that perfuse the heart. As the section of the artery decreases, so does the blood flow and therefore the supply of oxygen to the myocardium, which can cause angina pectoris or even an acute myocardial infarction.
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance. You may not know which one you got.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- people with Myocardial Ischemia and percutaneous transluminal coronary angioplasty
- both sexes
- over 18 years old
- under 80 years of age
- absence of cognitive deficits and/or physical limitations that would prevent them from performing physical exercise or completing the questionnaires...
You likely can't join if
- disease or condition that contraindicates exercise such as severe hypertrophic obstructive cardiomyopathy
- severe aortic stenosis and/or dissecting aortic aneurysm
- patients who refuse treatment or do not sign the informed consent.
The study team makes the final eligibility decision.
Where it's taking place
- Málaga, Spain
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Málaga, Spain. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.